RE:RE:RE:Redemption of $575 Million 2.50% Convertible Senior NotesGreat point. The Biopharma industry I work in uses Chinese companies widely for their many outstanding qualities. We are now having to reconsider for the sort of reasons you mention. This will only get worse.